Before the Open (Jun 5)

Good morning. Happy Monday. Hope you had a good weekend.
The Asian/Pacific markets closed with a lean to the upside. South Korea, New Zealand, Taiwan, Malaysia and the Philippines did well; China and Australia dropped. Europe is currently mixed. Germany, Greece, Denmark and Hungary are doing well; Poland, France, Italy and Portugal are weak. Futures in the States point towards a down open for the cash market.
—————
SUBSCRIBE to LB Weekly – it’s only $12.40/month when you sub for a year.
—————
The US dollar is up. Oil and copper are down. Gold and silver are up. Bonds are down.
We enter this new week with the Dow, Dow Composite, Nas, Nas 100, NYSE, Russell 1000, Russell 3000, S&P 100, S&P 500 and Wilshire 5000 having moved to new all-time highs, and the Russell 2000, S&P 600 and S&P 400 being pretty close.
Many of the market’s breadth indicators have improved the last couple weeks.
The trend is solidly up. It’s strong. It’s healthy. And although there will be disruptions along the way there’s no reason to believe it won’t continue. This is what I’ve been saying for a long time. I occasionally get made fun of, and here we are at the highs. The only side of the market to be on is the long side.
Premarket movers from thestockmarketwatch.com…

Stock headlines from barchart.com…
Apple (AAPL +1.48%) was downgraded to ‘Sector Weight’ from ‘Overweight’ at Pacific Crest Securities.
Perrigo (PRGO -1.73%) was downgraded to ‘Underperform’ from ‘Sector Perform’ at RBC Capital Markets.
Navistar (NAV -2.09%) was upgraded to ‘Outperform’ from ‘Neutral’ at Baird with a price target of $33.
Skechers (SKX +0.72%) was upgraded to ‘Positive’ from ‘Neutral’ at Susquehanna with a price target of $32.
Yelp (YELP -0.14%) was upgraded to ‘Buy’ from ‘Neutral’ at Bank of America/Merrill Lynch with a price target of $37.
Veeva Systems (VEEV +2.82%) was downgraded to ‘Equalweight’ from ‘Overweight’ at Morgan Stanley.
Hilton Worldwide Holdings (HLT +1.16%) was rated a new ‘Buy’ at Argus Research with a price target of $80.
State Street (STT -0.17%) was upgraded to ‘Buy’ from ‘Neutral’ at UBS with a price target of $92.
NewLink Genetics (NLNK -1.25%) dropped over 8% in after-hours trading after it said a combination of its indoximod with chemotherapy failed to show a significant difference in a Phase 2 study.
Dynavax Technologies (DVAX +4.42%) surged 18% in after-hours trading after it said a combo of its SD-101 plus Merck’s Keytruda resulted in a 100% response rate and 29% complete response in 7 melanoma patients and that SD 101 also helped shrink tumors in 42% of 12 patients who had previously failed PD-1 treatment.
Today’s Economic Calendar
8:30 Productivity and Costs
8:30 Gallup US Consumer Spending Measure
9:45 PMI Services Index
10:00 Labor market condition index
10:00 Factory Orders
10:00 ISM Non-Manufacturing Index
12:30 PM TD Ameritrade IMX
Other…



today’s upgrades/downgrades from briefing.com
this week’s Earnings from Morningstar
this week’s Economic Numbers/Reports powered by ECONODAY